title: [Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].
authors: Kardiologische Praxis und Praxisklinik, Akademische Lehrpraxis der Ludwig-Maximilans-Universität München, Germany. sigmund@silber.com
authors: S
authors: S
authors: Silber
authors: T M
authors: TM
authors: Helms
authors: C
authors: C
authors: Garlichs
authors: H-R
authors: HR
authors: Arntz
authors: J
authors: J
authors: Weil
authors: H
authors: H
authors: Ince
authors: T
authors: T
authors: Klingenheben
authors: S
authors: S
authors: Hoffmann
authors: E
authors: E
authors: Boudriot
authors: H
authors: H
authors: Steiger
authors: C
authors: C
authors: Zugck
mesh_terms: D054058:Acute Coronary Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D004359:Drug Therapy, Combination; D004562:Electrocardiography / Q000187:drug effects; D006470:Hemorrhage / Q000139:chemically induced / Q000401:mortality; D006801:Humans; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D000068799:Prasugrel Hydrochloride; D058921:Purinergic P2Y Receptor Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D013876:Thiophenes / Q000009:adverse effects / Q000627:therapeutic use*; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D013876:Thiophenes; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D013988:Ticlopidine